$0.00070
0.000.00%
At close: -
$0.00050
-0.00020-28.57%
After Hours: Jan 22, 4:00 PM EDT
Comments
Loading...
Sorrento Therapeutics Earnings Estimates, EPS & Revenue | OTC:SRNE | Benzinga
Sorrento Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 8
EPS
$-0.200
Quarterly Revenue
$17.40M
Annual Revenue
(as of Jun 30)
(as of Jun 30)
$64.27M
Analyze the earnings history of Sorrento Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SRNE | Sorrento Therapeutics | -$0.40 | — | -$0.20 | — | $12.06M | — | $17.40M | — | 11/08/2022 | Get Alert |
| SRNE | Sorrento Therapeutics | -$0.57 | — | -$0.54 | — | $13.51M | — | $11.46M | — | 08/15/2022 | Get Alert |
| SRNE | Sorrento Therapeutics | $0.01 | — | -$0.12 | — | $14.26M | — | $18.39M | — | 05/06/2022 | Get Alert |
| SRNE | Sorrento Therapeutics | -$0.25 | — | -$0.47 | — | $11.51M | — | $13.08M | — | 03/11/2022 | Get Alert |
| SRNE | Sorrento Therapeutics | -$0.33 | -$0.21 | -$0.40 | -90.48% | $11.75M | $10.21M | $12.06M | 18.14% | 11/05/2021 | Get Alert |
| SRNE | Sorrento Therapeutics | -$0.36 | -$0.20 | -$0.57 | -185.00% | $9.01M | $10.13M | $13.51M | 33.38% | 08/06/2021 | Get Alert |
| SRNE | Sorrento Therapeutics | -$0.36 | $0.24 | $0.01 | -95.83% | $7.72M | $17.25M | $14.26M | -17.36% | 05/05/2021 | Get Alert |
| SRNE | Sorrento Therapeutics | -$0.41 | — | -$0.25 | — | $13.03M | — | $11.51M | — | 02/19/2021 | Get Alert |
| SRNE | Sorrento Therapeutics | -$0.50 | — | -$0.33 | — | $5.78M | — | $11.75M | — | 11/09/2020 | Get Alert |
| SRNE | Sorrento Therapeutics | -$0.47 | -$0.24 | -$0.36 | -50.00% | $6.48M | $7.90M | $9.01M | 14.01% | 08/04/2020 | Get Alert |
| SRNE | Sorrento Therapeutics | -$0.88 | -$0.20 | -$0.36 | -80.00% | $6.14M | $10.00M | $7.72M | -22.79% | 05/11/2020 | Get Alert |
Sorrento Therapeutics (SRNE) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2021-11-05 | $-0.40 | $-0.21 | -90.5 % |
| Q2 | 2021-08-06 | $-0.57 | $-0.20 | -185.0 % |
| Q1 | 2021-05-05 | $0.01 | $0.24 | -95.8 % |
| Q2 | 2020-08-04 | $-0.36 | $-0.24 | -50.0 % |
Sorrento Therapeutics (SRNE) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2021-11-05 | $12.06M | $10.21M | 18.1 % |
| Q2 | 2021-08-06 | $13.51M | $10.13M | 33.4 % |
| Q1 | 2021-05-05 | $14.26M | $17.25M | -17.4 % |
| Q2 | 2020-08-04 | $9.01M | $7.90M | 14.0 % |
FAQ
When is Sorrento Therapeutics (OTCEM:SRNE) reporting earnings?
Sorrento Therapeutics (SRNE) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 8, 2022 for Q3.
What were the latest earnings per share (EPS) for Sorrento Therapeutics (OTCEM:SRNE)?
Sorrento Therapeutics (SRNE) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 8, 2022 for Q3 and the Actual EPS was $-0.20, which missed the estimate of $0.00.
What were Sorrento Therapeutics’s (OTCEM:SRNE) revenues?
Sorrento Therapeutics (SRNE) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 8, 2022 for Q3 and the Actual Revenue was $17.4M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.